Inactive Instrument

Highlights Jounce Therapeutics, Inc.

Equities

JNCE

US4811161011

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

Concentra Biosciences, LLC completed the acquisition of Jounce Therapeutics, Inc. from Tang Capital Management, LLC and others.	23-05-02	CI
Redx confirms Jounce deal lapses, Tirupati seals deal	23-04-03	AN
Redx Pharma Shares Fall 5% as Merger With Jounce Therapeutics Fails	23-04-03	MT
Jounce dumps Redx Pharma for acquisition by Concentra; to cut 84% of jobs	23-03-27	RE
Redx Pharma Says Jounce Therapeutics Terminated Merger Deal; Shares Plunge 19%	23-03-27	MT
Jounce Therapeutics Agrees to be Acquired by Concentra Biosciences	23-03-27	MT
Redx Pharma's bid to buy Jounce snubbed by Concentra's higher offer	23-03-27	AN
Jounce Therapeutics, Inc. completed the acquisition of Redx Pharma Plc from a group of sellers and other shareholders.	23-03-26	CI
Jounce Therapeutics, Inc. Announces Results from Pre-Planned Data Review of INNATE Phase 2 Trial of JTX-8064 and Pimivalimab Demonstrating Deep and Durable Responses in Platinum Resistant Ovarian Cancer	23-03-16	CI
Redx Pharma Says Merger Target Jounce Therapeutics Received New Takeover Proposal; Stock Surges 34%	23-03-15	MT
Jounce Therapeutics Gets Unsolicited Takeover Offer From Concentra Biosciences	23-03-15	MT
Concentra Biosciences, LLC made a proposal to acquire Jounce Therapeutics, Inc. from Tang Capital Management, LLC and others for $94.8 million.	23-03-13	CI
Jounce Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-10	CI
JOUNCE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Jounce Therapeutics, Inc. - JNCE	23-02-27	BU
Redx Pharma and Jounce Therapeutics agree transatlantic merger	23-02-23	AN
Redx Pharma, Jounce Therapeutics Agree Merger Deal	23-02-23	MT
Biotech firms Redx Pharma and Jounce Therapeutics to combine business	23-02-23	RE
Jounce Therapeutics, Inc. and Redx Pharma plc Recommend Business Combination	23-02-23	CI
Jounce Therapeutics, Inc. have reached an agreement to acquire Redx Pharma Plc from a group of sellers and other shareholders for £58.1 million.	23-02-22	CI
Gilead Sciences to Acquire Remaining Rights to GS-1811 from Jounce Therapeutics	22-12-27	DJ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Jounce Therapeutics, Inc.

Equities

JNCE

US4811161011

Highlights

Filters